Aims
PD
Edited by: Ping Wang, Michigan State University, United StatesReviewed by: Satish Kumar Bedada, Novotech (Australia) Pty Limited, India; Benli Su, Second Hospital of Dalian Medical University, ChinaTo verify whether the oral insulin N11005 is administered as a prandial insulin by assessing the pharmacokinetics (PK), pharmacodynamics (PD), and safety profiles of N11005 with a short-acting biosynthetic human insulin (Novolin R) as reference.